Logo image of IOSP

INNOSPEC INC (IOSP) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:IOSP - US45768S1050 - Common Stock

79.86 USD
-2.03 (-2.48%)
Last: 1/16/2026, 8:00:02 PM
79.86 USD
0 (0%)
After Hours: 1/16/2026, 8:00:02 PM
Fundamental Rating

5

IOSP gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 82 industry peers in the Chemicals industry. While IOSP has a great health rating, its profitability is only average at the moment. IOSP has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • IOSP had positive earnings in the past year.
  • IOSP had a positive operating cash flow in the past year.
  • IOSP had positive earnings in each of the past 5 years.
  • In the past 5 years IOSP always reported a positive cash flow from operatings.
IOSP Yearly Net Income VS EBIT VS OCF VS FCFIOSP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -0.07%, IOSP is in line with its industry, outperforming 51.22% of the companies in the same industry.
  • IOSP's Return On Equity of -0.09% is in line compared to the rest of the industry. IOSP outperforms 54.88% of its industry peers.
  • IOSP has a Return On Invested Capital of 9.58%. This is amongst the best in the industry. IOSP outperforms 80.49% of its industry peers.
  • IOSP had an Average Return On Invested Capital over the past 3 years of 11.29%. This is significantly above the industry average of 6.11%.
Industry RankSector Rank
ROA -0.07%
ROE -0.09%
ROIC 9.58%
ROA(3y)6.16%
ROA(5y)5.29%
ROE(3y)9.29%
ROE(5y)7.99%
ROIC(3y)11.29%
ROIC(5y)9.61%
IOSP Yearly ROA, ROE, ROICIOSP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

  • In the last couple of years the Profit Margin of IOSP has declined.
  • IOSP's Operating Margin of 9.31% is in line compared to the rest of the industry. IOSP outperforms 51.22% of its industry peers.
  • In the last couple of years the Operating Margin of IOSP has remained more or less at the same level.
  • IOSP has a Gross Margin (28.01%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of IOSP has remained more or less at the same level.
Industry RankSector Rank
OM 9.31%
PM (TTM) N/A
GM 28.01%
OM growth 3Y3.11%
OM growth 5Y-0.56%
PM growth 3Y-32.51%
PM growth 5Y-23.61%
GM growth 3Y0.12%
GM growth 5Y-0.92%
IOSP Yearly Profit, Operating, Gross MarginsIOSP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

7

2. Health

2.1 Basic Checks

  • IOSP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, IOSP has more shares outstanding
  • The number of shares outstanding for IOSP has been increased compared to 5 years ago.
  • There is no outstanding debt for IOSP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
IOSP Yearly Shares OutstandingIOSP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
IOSP Yearly Total Debt VS Total AssetsIOSP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • IOSP has an Altman-Z score of 4.92. This indicates that IOSP is financially healthy and has little risk of bankruptcy at the moment.
  • IOSP has a better Altman-Z score (4.92) than 93.90% of its industry peers.
  • IOSP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.92
ROIC/WACC0.61
WACC15.84%
IOSP Yearly LT Debt VS Equity VS FCFIOSP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 2.78 indicates that IOSP has no problem at all paying its short term obligations.
  • IOSP has a Current ratio of 2.78. This is in the better half of the industry: IOSP outperforms 78.05% of its industry peers.
  • A Quick Ratio of 1.81 indicates that IOSP should not have too much problems paying its short term obligations.
  • The Quick ratio of IOSP (1.81) is better than 75.61% of its industry peers.
Industry RankSector Rank
Current Ratio 2.78
Quick Ratio 1.81
IOSP Yearly Current Assets VS Current LiabilitesIOSP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

3

3. Growth

3.1 Past

  • The earnings per share for IOSP have decreased strongly by -16.11% in the last year.
  • Measured over the past 5 years, IOSP shows a small growth in Earnings Per Share. The EPS has been growing by 2.75% on average per year.
  • Looking at the last year, IOSP shows a decrease in Revenue. The Revenue has decreased by -4.49% in the last year.
  • The Revenue has been growing slightly by 4.05% on average over the past years.
EPS 1Y (TTM)-16.11%
EPS 3Y7.65%
EPS 5Y2.75%
EPS Q2Q%-17.04%
Revenue 1Y (TTM)-4.49%
Revenue growth 3Y7.55%
Revenue growth 5Y4.05%
Sales Q2Q%-0.34%

3.2 Future

  • Based on estimates for the next years, IOSP will show a small growth in Earnings Per Share. The EPS will grow by 2.47% on average per year.
  • The Revenue is expected to grow by 2.57% on average over the next years.
EPS Next Y-14.21%
EPS Next 2Y-2.69%
EPS Next 3Y2.47%
EPS Next 5YN/A
Revenue Next Year-2.31%
Revenue Next 2Y1.31%
Revenue Next 3Y2.57%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
IOSP Yearly Revenue VS EstimatesIOSP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
IOSP Yearly EPS VS EstimatesIOSP Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 15.04 indicates a correct valuation of IOSP.
  • Based on the Price/Earnings ratio, IOSP is valued a bit cheaper than the industry average as 69.51% of the companies are valued more expensively.
  • IOSP's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.38.
  • IOSP is valuated correctly with a Price/Forward Earnings ratio of 14.06.
  • Based on the Price/Forward Earnings ratio, IOSP is valued a bit cheaper than 67.07% of the companies in the same industry.
  • IOSP is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 24.29, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 15.04
Fwd PE 14.06
IOSP Price Earnings VS Forward Price EarningsIOSP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 73.17% of the companies in the same industry are more expensive than IOSP, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of IOSP is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 71.96
EV/EBITDA 8.07
IOSP Per share dataIOSP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)5.48
EPS Next 2Y-2.69%
EPS Next 3Y2.47%

5

5. Dividend

5.1 Amount

  • IOSP has a Yearly Dividend Yield of 2.12%. Purely for dividend investing, there may be better candidates out there.
  • IOSP's Dividend Yield is a higher than the industry average which is at 2.28.
  • IOSP's Dividend Yield is comparable with the S&P500 average which is at 1.85.
Industry RankSector Rank
Dividend Yield 2.12%

5.2 History

  • The dividend of IOSP is nicely growing with an annual growth rate of 8.78%!
  • IOSP has been paying a dividend for at least 10 years, so it has a reliable track record.
  • IOSP has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)8.78%
Div Incr Years11
Div Non Decr Years11
IOSP Yearly Dividends per shareIOSP Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

  • IOSP has negative earnings and hence a negative payout ratio. The dividend may be in danger.
  • The dividend of IOSP is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP-3383.33%
EPS Next 2Y-2.69%
EPS Next 3Y2.47%
IOSP Yearly Income VS Free CF VS DividendIOSP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

INNOSPEC INC

NASDAQ:IOSP (1/16/2026, 8:00:02 PM)

After market: 79.86 0 (0%)

79.86

-2.03 (-2.48%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-05
Earnings (Next)02-17
Inst Owners99.65%
Inst Owner Change0.29%
Ins Owners1%
Ins Owner Change0.05%
Market Cap1.98B
Revenue(TTM)1.79B
Net Income(TTM)-1.20M
Analysts82.22
Price Target101.32 (26.87%)
Short Float %1.75%
Short Ratio1.75
Dividend
Industry RankSector Rank
Dividend Yield 2.12%
Yearly Dividend1.56
Dividend Growth(5Y)8.78%
DP-3383.33%
Div Incr Years11
Div Non Decr Years11
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.56%
Min EPS beat(2)-2.48%
Max EPS beat(2)3.59%
EPS beat(4)2
Avg EPS beat(4)2.06%
Min EPS beat(4)-2.48%
Max EPS beat(4)8.85%
EPS beat(8)4
Avg EPS beat(8)2.71%
EPS beat(12)6
Avg EPS beat(12)2.32%
EPS beat(16)10
Avg EPS beat(16)6.92%
Revenue beat(2)0
Avg Revenue beat(2)-1.4%
Min Revenue beat(2)-1.84%
Max Revenue beat(2)-0.96%
Revenue beat(4)1
Avg Revenue beat(4)-1.75%
Min Revenue beat(4)-6.47%
Max Revenue beat(4)2.28%
Revenue beat(8)2
Avg Revenue beat(8)-2.68%
Revenue beat(12)4
Avg Revenue beat(12)-2.35%
Revenue beat(16)8
Avg Revenue beat(16)0.49%
PT rev (1m)0%
PT rev (3m)-11.7%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-16.4%
EPS NY rev (1m)0%
EPS NY rev (3m)-6.37%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.04%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.36%
Valuation
Industry RankSector Rank
PE 15.04
Fwd PE 14.06
P/S 1.11
P/FCF 71.96
P/OCF 19.29
P/B 1.53
P/tB 2.37
EV/EBITDA 8.07
EPS(TTM)5.31
EY6.65%
EPS(NY)5.68
Fwd EY7.11%
FCF(TTM)1.11
FCFY1.39%
OCF(TTM)4.14
OCFY5.18%
SpS72.2
BVpS52.34
TBVpS33.65
PEG (NY)N/A
PEG (5Y)5.48
Graham Number79.08
Profitability
Industry RankSector Rank
ROA -0.07%
ROE -0.09%
ROCE 11.54%
ROIC 9.58%
ROICexc 11.8%
ROICexgc 19.5%
OM 9.31%
PM (TTM) N/A
GM 28.01%
FCFM 1.54%
ROA(3y)6.16%
ROA(5y)5.29%
ROE(3y)9.29%
ROE(5y)7.99%
ROIC(3y)11.29%
ROIC(5y)9.61%
ROICexc(3y)13.47%
ROICexc(5y)11.26%
ROICexgc(3y)22.5%
ROICexgc(5y)18.82%
ROCE(3y)13.59%
ROCE(5y)11.57%
ROICexgc growth 3Y13.46%
ROICexgc growth 5Y3.02%
ROICexc growth 3Y11.53%
ROICexc growth 5Y3.76%
OM growth 3Y3.11%
OM growth 5Y-0.56%
PM growth 3Y-32.51%
PM growth 5Y-23.61%
GM growth 3Y0.12%
GM growth 5Y-0.92%
F-Score5
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 166.52%
Cap/Sales 4.2%
Interest Coverage 250
Cash Conversion 48.49%
Profit Quality N/A
Current Ratio 2.78
Quick Ratio 1.81
Altman-Z 4.92
F-Score5
WACC15.84%
ROIC/WACC0.61
Cap/Depr(3y)148.38%
Cap/Depr(5y)120.26%
Cap/Sales(3y)3.16%
Cap/Sales(5y)2.92%
Profit Quality(3y)155.47%
Profit Quality(5y)185.88%
High Growth Momentum
Growth
EPS 1Y (TTM)-16.11%
EPS 3Y7.65%
EPS 5Y2.75%
EPS Q2Q%-17.04%
EPS Next Y-14.21%
EPS Next 2Y-2.69%
EPS Next 3Y2.47%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.49%
Revenue growth 3Y7.55%
Revenue growth 5Y4.05%
Sales Q2Q%-0.34%
Revenue Next Year-2.31%
Revenue Next 2Y1.31%
Revenue Next 3Y2.57%
Revenue Next 5YN/A
EBIT growth 1Y-8.06%
EBIT growth 3Y10.9%
EBIT growth 5Y3.46%
EBIT Next Year8.35%
EBIT Next 3Y10.13%
EBIT Next 5YN/A
FCF growth 1Y-80.63%
FCF growth 3Y31.21%
FCF growth 5Y-1.32%
OCF growth 1Y-51.9%
OCF growth 3Y25.56%
OCF growth 5Y2.69%

INNOSPEC INC / IOSP FAQ

Can you provide the ChartMill fundamental rating for INNOSPEC INC?

ChartMill assigns a fundamental rating of 5 / 10 to IOSP.


What is the valuation status of INNOSPEC INC (IOSP) stock?

ChartMill assigns a valuation rating of 4 / 10 to INNOSPEC INC (IOSP). This can be considered as Fairly Valued.


What is the profitability of IOSP stock?

INNOSPEC INC (IOSP) has a profitability rating of 5 / 10.


How financially healthy is INNOSPEC INC?

The financial health rating of INNOSPEC INC (IOSP) is 7 / 10.


How sustainable is the dividend of INNOSPEC INC (IOSP) stock?

The dividend rating of INNOSPEC INC (IOSP) is 5 / 10 and the dividend payout ratio is -3383.33%.